📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Angle

1.1 - Company Overview

Angle Logo

Angle

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of liquid biopsy cancer diagnostic products for the capture and harvest of circulating tumor cells.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Angle

Cellerant Therapeutics Logo

Cellerant Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage cell- and antibody-based immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellerant Therapeutics company profile →
Tube Pharma Logo

Tube Pharma

HQ: Austria Website
  • Description: Provider of biopharmaceutical research and development focused on cancer medicines, conducting pharmaceutical R&D for pancreatic, lung, and breast cancers, and collaborating with academic institutions and other biopharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tube Pharma company profile →
Nkarta Logo

Nkarta

HQ: United States Website
  • Description: Provider of a cell engineering platform for next-generation cell therapies, offering allogeneic off-the-shelf CAR-NK treatments including NKX101, an NKG2D CAR-NK for hematologic malignancies and solid tumors, and NKX019, a CD19-targeting CAR-NK for B-cell malignancies, supported by a proprietary allogeneic manufacturing process for NK cell collection, activation, engineering, expansion, and cryopreservation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nkarta company profile →
Viventia Bio Logo

Viventia Bio

HQ: Canada Website
  • Description: Provider of next-generation oncology therapeutics utilizing proprietary Targeted Protein Therapeutic (TPT) technology; a privately held biopharmaceutical company focused on the discovery and development of TPT-based product candidates with potential advantages in treating cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viventia Bio company profile →
Paradigm Logo

Paradigm

HQ: United States Website
  • Description: Provider of cutting-edge molecular diagnostics and biomarker-driven clinical trials for cancer patients and industry, using Next-Gen Sequencing and other biomarker analysis to deliver information on the genomic and proteomic landscape of a patient's cancer and potential therapies based on specific characterization of the cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Paradigm company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Angle

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Angle

2.2 - Growth funds investing in similar companies to Angle

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Angle

4.2 - Public trading comparable groups for Angle

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Angle

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Angle

What does Angle do?

Angle is a provider of liquid biopsy cancer diagnostic products for the capture and harvest of circulating tumor cells.

Who are Angle's competitors?

Angle's competitors and similar companies include Cellerant Therapeutics, Tube Pharma, Nkarta, Viventia Bio, and Paradigm.

Where is Angle headquartered?

Angle is headquartered in United Kingdom.

How many employees does Angle have?

Angle has 1,000 employees 🔒.

When was Angle founded?

Angle was founded in 2010 🔒.

What sector and industry vertical is Angle in?

Angle is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Angle

Who are the top strategic acquirers in Angle's sector and industry

Top strategic M&A buyers and acquirers in Angle's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Angle?

Top strategic M&A buyers groups and sectors for Angle include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Angle's sector and industry vertical

Which are the top PE firms investing in Angle's sector and industry vertical?

Top PE firms investing in Angle's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Angle's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Angle's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Angle's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Angle include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Angle's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Angle?

The key public trading comparables and valuation benchmarks for Angle include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Angle for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Angle with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Angle's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Angle with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Angle's' sector and industry vertical?

Access recent funding rounds and capital raises in Angle's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Angle